BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31217079)

  • 1. Colic and rectal tumors with peritoneal metastases treated with cytoreductive surgery and HIPEC: One homogeneous condition or two different diseases? A systematic review and meta-analysis.
    Tonello M; Sommariva A; Pirozzolo G; Mattara G; Pilati P
    Eur J Surg Oncol; 2019 Nov; 45(11):2003-2008. PubMed ID: 31217079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study.
    Simkens GA; van Oudheusden TR; Braam HJ; Wiezer MJ; Nienhuijs SW; Rutten HJ; van Ramshorst B; de Hingh IH
    J Surg Oncol; 2016 Apr; 113(5):548-53. PubMed ID: 27110701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases.
    Tonello M; Ortega-Perez G; Alonso-Casado O; Torres-Mesa P; Guiñez G; Gonzalez-Moreno S
    Clin Transl Oncol; 2018 Oct; 20(10):1268-1273. PubMed ID: 29667123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.
    Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS
    Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
    de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
    Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study.
    Hammoudi N; Eveno C; Lambert J; Maillet M; Glehen O; Goere D; Lourenco N; Allez M; Aparicio T; Pocard M; Gornet JM;
    Eur J Surg Oncol; 2018 Jun; 44(6):799-804. PubMed ID: 29650418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre.
    Alzahrani N; Ung L; Valle SJ; Liauw W; Morris DL
    ANZ J Surg; 2017 Nov; 87(11):E167-E172. PubMed ID: 26178318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience.
    Gupta N; Asif S; Gandhi J; Rajpurohit S; Singh S
    Indian J Gastroenterol; 2017 Mar; 36(2):126-130. PubMed ID: 28393331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
    van Eden WJ; Kok NFM; Woensdregt K; Huitema ADR; Boot H; Aalbers AGJ
    Eur J Surg Oncol; 2018 Feb; 44(2):220-227. PubMed ID: 29258720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative and Oncological Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis of Rectal Origin.
    Benvenisti H; Shiber M; Assaf D; Shovman Y; Laks S; Elbaz N; Mor E; Zippel D; Nissan A; Ben-Yaacov A; Adileh M
    J Gastrointest Surg; 2023 Nov; 27(11):2506-2514. PubMed ID: 37726508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study.
    Mehta S; Schwarz L; Spiliotis J; Hsieh MC; Akaishi EH; Goere D; Sugarbaker PH; Baratti D; Quenet F; Bartlett DL; Villeneuve L; Kepenekian V;
    Eur J Surg Oncol; 2018 Nov; 44(11):1786-1792. PubMed ID: 29885982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Tonello M; Baratti D; Sammartino P; Di Giorgio A; Robella M; Sassaroli C; Framarini M; Valle M; Macrì A; Graziosi L; Coccolini F; Lippolis PV; Gelmini R; Deraco M; Biacchi D; Santullo F; Vaira M; Di Lauro K; D'Acapito F; Carboni F; Giuffrè G; Donini A; Fugazzola P; Faviana P; Sorrentino L; Scapinello A; Del Bianco P; Sommariva A
    Ann Surg Oncol; 2022 Jun; 29(6):3405-3417. PubMed ID: 34783946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of radiological retroperitoneal lymphadenopathy on survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases.
    van der Werf LR; Wassenaar E; de Niet A; Lalezari F; Braam HJ; van Ramshorst B; Nederend J; de Hingh IHJT; Kok NFM; Aalbers AGJ
    Eur J Surg Oncol; 2019 Mar; 45(3):376-382. PubMed ID: 30414704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
    Kotha NV; Baumgartner JM; Veerapong J; Cloyd JM; Ahmed A; Grotz TE; Leiting JL; Fournier K; Lee AJ; Dineen SP; Dessureault S; Clarke C; Mogal H; Zaidi MY; Russell MC; Patel SH; Sussman JJ; Dhar V; Lambert LA; Hendrix RJ; Abbott DE; Pokrzywa C; Lafaro K; Lee B; Greer JB; Fackche N; Lowy AM; Kelly KJ
    Ann Surg Oncol; 2019 Jul; 26(7):2234-2240. PubMed ID: 31016486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases.
    Ito K; Takemura N; Inagaki F; Mihara F; Kurokawa T; Gohda Y; Kiyomatsu T; Yano H; Kokudo N
    World J Surg Oncol; 2019 Jun; 17(1):99. PubMed ID: 31196097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
    Baratti D; Kusamura S; Azmi N; Guaglio M; Montenovo M; Deraco M
    Ann Surg Oncol; 2020 Jan; 27(1):98-106. PubMed ID: 31691116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.
    Wong JF; Tan GH; Wang W; Soo KC; Teo MC
    World J Surg; 2015 Jun; 39(6):1578-83. PubMed ID: 25651962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and HIPEC: preliminary results in highly selected patients.
    Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2013 Dec; 68(6):551-8. PubMed ID: 24193287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for endometrial cancer-derived peritoneal metastases: a systematic review.
    Tempfer CB; Kern P; Dogan A; Hilal Z; Rezniczek GA
    Clin Exp Metastasis; 2019 Aug; 36(4):321-329. PubMed ID: 31089843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.